Skip to main content
Paul S. Bernstein
( out of 384 reviews )

Paul S. Bernstein, MD, PhD

Languages spoken: English

Clinical Locations

John A. Moran Eye Center

Salt Lake City
801-581-2352

Midvalley Health Center

Murray
801-585-3937
  • Paul S. Bernstein, MD, PhD, divides his time between basic science retina research and a clinical practice devoted to medical and surgical treatment of diseases of the retina at the John A. Moran Eye Center at the University of Utah, where he has been a faculty member since 1995. He holds the Val A. and Edith D. Green Presidential Endowed Chair in Ophthalmology and Visual Sciences and is Moran’s Director of Clinical Research and Associate Director of Research. He has adjunct appointments in the University of Utah Department of Pharmacology and Toxicology, Department of Neurobiology and Anatomy, and Division of Neurosciences.

    His clinical expertise includes age-related macular degeneration with special emphasis on the role of nutrition and environment in its treatment and prevention, inherited retinal and macular dystrophies, and surgical treatment of vitreoretinal disorders such as diabetic retinopathy and retinal detachments.

    Dr. Bernstein did his undergraduate, MD, and PhD training at Harvard University. Highlights of his training at Harvard included a summa cum laude undergraduate degree in chemistry and a PhD thesis entitled “Biochemistry and Pharmacology of Rhodopsin Regeneration in the Vertebrate Eye” with Dr. Robert Rando of the Department of Pharmacology. His medical degree was from the Division of Health Sciences and Technology, a special joint program between Harvard Medical School and the Massachusetts Institute of Technology. After completing 12 years at Harvard, he moved to UCLA where he did a post-doctoral fellowship with Dr. Dean Bok in retinal cell biology and a residency in Ophthalmology at the Jules Stein Eye Institute. He then returned to Harvard for two more years for a fellowship in vitreoretinal research and surgery at the Massachusetts Eye and Ear Infirmary.

    Dr. Bernstein has authored over 200 peer-reviewed research articles and reviews as well as over a dozen book chapters and has served as a reviewer for numerous journals, foundations, and institutes. His lab research interests include biochemistry and biophysics of nutritional interventions against inherited and acquired ocular disorders and the genetics and imaging of macular telangiectasia type 2 (MacTel)—a notoriously difficult-to-diagnose hereditary disease that causes central vision loss. He is among the first researchers worldwide to test the early diagnostic capabilities of fluorescence lifetime imaging ophthalmoscopy, a new non-invasive retinal imaging technique known as FLIO.

    He has received numerous awards, including the 2020 Mildred Weisenfeld Award from the Association for Research in Vision and Ophthalmology; the Macula Society’s 2019 W. Richard Green Lecture in honor of work that has helped explain the pathogenesis of retinal diseases; and the American Academy of Ophthalmology’s 2016 Outstanding Humanitarian Service Award.

    Dr. Bernstein is also dedicated to bringing modern vitreoretinal services to the developing world in a sustainable manner. Currently, access to retinal care is extremely limited in many parts of the world, and Dr. Bernstein provides hands-on specialty training to help expand the availability and quality of care. Dr. Bernstein has worked with Moran’s Global Outreach Division and the Himalayan Cataract Project to train aspiring retina specialists from Nepal, Ghana, Ethiopia, and Bhutan.

    Get to know Dr. Bernstein by watching his profile video.

    Board Certification

    American Board of Ophthalmology
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 384 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 30, 2024
    MORAN EYE CENTER

    I wish that he was more engaged and interested in me as a person. He always seems very rushed, with no time to be even slightly friendly or to ask how my vision loss is going.

    April 28, 2024
    MORAN EYE CENTER

    Dr.Bernstein is caring for my problem in a very good way , which I¿m very happy with. B

    April 28, 2024
    MORAN EYE CENTER

    Dear Dr. Paul S Bernstein, MD Thank you from the bottom of my heart for my retina detachment emergency surgery. You and the other doctors acted upon so fast to perform my emergency surgery after finding out about my Retina detachment that morning during my visit for my ESCLERA that got healed after eight weeks of treatment from 2/20/24-4/25/24. Again thank you for acting up fast enough without hesitation to perform the Retina surgery. Forever grateful to you and your Young Dr assistant during my surgery. Gracias!

    April 24, 2024
    MORAN EYE CENTER

    Explained the procedure and followed up with explaining the surgical outcome.

    April 24, 2024
    MORAN EYE CENTER

    Dr. Bernstein made me feel comfortable and confident that I was in good hands from the moment he entered the room and introduced himself. He listed to me and explained everything so I really didn't have any questions. I never felt rushed. I actually enjoyed going to see him.

    April 23, 2024
    MORAN EYE CENTER

    He is a very good eye doctor.

    April 22, 2024
    MORAN EYE CENTER

    I highly recommend Moran and the help I received!

    April 20, 2024
    MORAN EYE CENTER

    Dr Bernstein is the best. I owe my sight to him.

    April 14, 2024
    MORAN EYE CENTER

    Excellent care. The procedure was explained in a way that I could understand.

  • Paul S. Bernstein, MD, PhD, divides his time between basic science retina research and a clinical practice devoted to medical and surgical treatment of diseases of the retina at the John A. Moran Eye Center at the University of Utah, where he has been a faculty member since 1995. He holds the Val A. and Edith D. Green Presidential Endowed Chair in Ophthalmology and Visual Sciences and is Moran’s Director of Clinical Research and Associate Director of Research. He has adjunct appointments in the University of Utah Department of Pharmacology and Toxicology, Department of Neurobiology and Anatomy, and Division of Neurosciences.

    His clinical expertise includes age-related macular degeneration with special emphasis on the role of nutrition and environment in its treatment and prevention, inherited retinal and macular dystrophies, and surgical treatment of vitreoretinal disorders such as diabetic retinopathy and retinal detachments.

    Dr. Bernstein did his undergraduate, MD, and PhD training at Harvard University. Highlights of his training at Harvard included a summa cum laude undergraduate degree in chemistry and a PhD thesis entitled “Biochemistry and Pharmacology of Rhodopsin Regeneration in the Vertebrate Eye” with Dr. Robert Rando of the Department of Pharmacology. His medical degree was from the Division of Health Sciences and Technology, a special joint program between Harvard Medical School and the Massachusetts Institute of Technology. After completing 12 years at Harvard, he moved to UCLA where he did a post-doctoral fellowship with Dr. Dean Bok in retinal cell biology and a residency in Ophthalmology at the Jules Stein Eye Institute. He then returned to Harvard for two more years for a fellowship in vitreoretinal research and surgery at the Massachusetts Eye and Ear Infirmary.

    Dr. Bernstein has authored over 200 peer-reviewed research articles and reviews as well as over a dozen book chapters and has served as a reviewer for numerous journals, foundations, and institutes. His lab research interests include biochemistry and biophysics of nutritional interventions against inherited and acquired ocular disorders and the genetics and imaging of macular telangiectasia type 2 (MacTel)—a notoriously difficult-to-diagnose hereditary disease that causes central vision loss. He is among the first researchers worldwide to test the early diagnostic capabilities of fluorescence lifetime imaging ophthalmoscopy, a new non-invasive retinal imaging technique known as FLIO.

    He has received numerous awards, including the 2020 Mildred Weisenfeld Award from the Association for Research in Vision and Ophthalmology; the Macula Society’s 2019 W. Richard Green Lecture in honor of work that has helped explain the pathogenesis of retinal diseases; and the American Academy of Ophthalmology’s 2016 Outstanding Humanitarian Service Award.

    Dr. Bernstein is also dedicated to bringing modern vitreoretinal services to the developing world in a sustainable manner. Currently, access to retinal care is extremely limited in many parts of the world, and Dr. Bernstein provides hands-on specialty training to help expand the availability and quality of care. Dr. Bernstein has worked with Moran’s Global Outreach Division and the Himalayan Cataract Project to train aspiring retina specialists from Nepal, Ghana, Ethiopia, and Bhutan.

    Get to know Dr. Bernstein by watching his profile video.

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Primary
    Neurobiology -Adjunct
    Board Certification
    American Board of Ophthalmology
    National Board of Medical Examiners

    Education history

    Fellowship Vitreoretinal Surgery - Massachusetts Eye and Ear Infirmary Fellow
    Ophthalmology - UCLA Medical Center, Jules Stein Eye Institute Resident
    Postdoctoral Fellowship Cell Biology - UCLA Medical Center, Jules Stein Eye Institute Postdoctoral Fellow
    Internal Medicine - New England Deaconess Hospital Intern
    Doctoral Training Pharmacology - Harvard University Ph.D.
    Medicine - Harvard Medical School/MIT - Division of Health Sciences & Technology M.D.
    Undergraduate Chemistry, summa cum laude - Harvard University A.B.

    Selected Publications

    Journal Article

    1. Nwagbo U, Parvez S, Maschek JA, Bernstein PS (2024). Elovl4b knockout zebrafish as a model for ocular very-long-chain PUFA deficiency. J Lipid Res, 65(3), 100518. (Read full article)
    2. Bernstein PS (2024). Potassium Iodate Retinotoxicity after an Overdose of Anti-Radiation Pills: A Case of Apocalyptic Retinopathy. Retin Cases Brief Rep. (Read full article)
    3. Amoaku WM, Cushley L, Silvestri V, Akafo S, Amissah-Arthur KN, Lartey S, Hageman CN, Pappas CM, Hubbard WC, Bernstein PS, Vitale A, Roberts M, Virgili G, Hageman GS, Silvestri G, Ghana AMD Study Group (2023). Vitreomacular interface abnormalities in the Ghanaian African. Eye (Lond). (Read full article)
    4. Posselli NR, Bernstein PS, Abbott JJ (2023). Eye-mounting goggles to bridge the gap between benchtop experiments and in vivo robotic eye surgery. Sci Rep, 13(1), 15503. (Read full article)
    5. Sauer L, Vitale AS, Jacoby RS, Hart B, Bernstein PS (2023). FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 WITH AND WITHOUT DIABETES. Retina, 43(9), 1597-1607. (Read full article)
    6. Addo EK, Allman SJ, Arunkumar R, Gorka JE, Harrison DY, Varner MW, Bernstein PS (2023). Systemic Effects of Prenatal Carotenoid Supplementation in the Mother and her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial -Report Number 1. J Nutr, 153(8), 2205-2215. (Read full article)
    7. Addo EK, Hartnett ME, Bernstein PS (2023). The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial. Trials, 24(1), 414. (Read full article)
    8. Eade KT, Ansell BRE, Giles S, Fallon R, Harkins-Perry S, Nagasaki T, Tzaridis S, Wallace M, Mills EA, Farashi S, Johnson A, Sauer L, Hart B, Diaz-Rubio ME, Bahlo M, Metallo C, Allikmets R, Gantner ML, Bernstein PS, Friedlander M (2023). iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function. J Clin Invest, 133(9). (Read full article)
    9. Rai BB, Essex RW, Morley MG, Bernstein PS, van Kleef JP, Maddess T (2023). Prevalence and severity of diabetic retinopathy at first presentation to vitreoretinal services in Bhutan: a 3-year national study. Jpn J Ophthalmol. (Read full article)
    10. Arunkumar R, Li B, Addo EK, Hartnett ME, Bernstein PS (2023). Prenatal Carotenoid Supplementation With Lutein or Zeaxanthin Ameliorates Oxygen-Induced Retinopathy (OIR) in Bco2-/- Macular Pigment Mice. Invest Ophthalmol Vis Sci, 64(4), 9. (Read full article)
    11. Thapa R, Addo EK, Ruit S, Bernstein PS (2023). Assessment of Skin Carotenoid Measurement as a Means to Detect Vitamin A Deficiency in Children and Pregnant Women of Nepal. J Nutr, 153(4), 1211-1219. (Read full article)
    12. Li B, George EW, Vachali P, Chang FY, Gorusupudi A, Arunkumar R, Giauque NA, Wan Z, Frederick JM, Bernstein PS (2023). Mechanism for the selective uptake of macular carotenoids mediated by the HDL cholesterol receptor SR-BI. Exp Eye Res, 229, 109429. (Read full article)
    13. Green CR, Bonelli R, Ansell BRE, Tzaridis S, Handzlik MK, McGregor GH, Hart B, Trombley J, Reilly MM, Bernstein PS, Egan C, Fruttiger M, Wallace M, Bahlo M, Friedlander M, Metallo CM, Gantner ML (2023). Divergent amino acid and sphingolipid metabolism in patients with inherited neuro-retinal disease. Mol Metab, 72, 101716. (Read full article)
    14. Gorusupudi A, Nwagbo U, Bernstein PS (2023). Role of VLC-PUFAs in Retinal and Macular Degeneration. Adv Exp Med Biol, 1415, 257-261. (Read full article)
    15. Etheridge T, Swiston C, Harrie RP, Bernstein PS (2022). Acute post-traumatic endophthalmitis secondary to Bacillus pumilus/safensis. Retin Cases Brief Rep. (Read full article)
    16. Cheng V, Rallabandi R, Gorusupudi A, Lucas S, Rognon G, Bernstein PS, Rainier JD, Conboy JC (2022). Influence of very-long-chain polyunsaturated fatty acids on membrane structure and dynamics. Biophys J, 121(14), 2730-2741. (Read full article)
    17. Rai BB, Morley MG, Bernstein PS, Maddess T (2022). Severity of age-related macular degeneration at first presentation in Bhutan: a 3-year national study. BMC Ophthalmol, 22(1), 298. (Read full article)
    18. Bernstein PS (2022). Nourishing Better Vision: The ARVO 2021 Mildred Weisenfeld Award Lecture. Invest Ophthalmol Vis Sci, 63(3), 13. (Read full article)
    19. Li B, Vachali P, Chang FY, Gorusupudi A, Arunkumar R, Shi L, Rognon GT, Frederick JM, Bernstein PS (2021). HDL is the primary transporter for carotenoids from liver to retinal pigment epithelium in transgenic ApoA-I-/-/Bco2-/- mice. Arch Biochem Biophys, 716, 109111. (Read full article)
    20. Li B, Gorusupudi A, Arunkumar R, Bernstein PS (2022). Extraction, detection, and imaging of the macular carotenoids. Methods Enzymol, 674, 185-213. (Read full article)
    21. Takayanagi Y, Obana A, Muto S, Asaoka R, Tanito M, Ermakov IV, Bernstein PS, Gellermann W (2021). Relationships between Skin Carotenoid Levels and Metabolic Syndrome. Antioxidants (Basel), 11(1). (Read full article)
    22. Obana A, Gohto Y, Asaoka R, Gellermann W, Bernstein PS (2021). Lutein and Zeaxanthin Distribution in the Healthy Macula and Its Association with Various Demographic Factors Examined in Pseudophakic Eyes. Antioxidants (Basel), 10(12). (Read full article)
    23. Iannaccone A, Brewer CC, Cheng P, Duncan JL, Maguire MG, Audo I, Ayala AR, Bernstein PS, Bidelman GM, Cheetham JK, Doty RL, Durham TA, Hufnagel RB, Myers MH, Stingl K, Zein WM, Foundation Fighting Blindness Consortium Investigator Group (2021). Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A). Am J Med Genet A, 185, 3717-3727. (Read full article)
    24. Sauer L, Vitale AS, Modersitzki NK, Bernstein PS (2021). LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel). Retina, 41(7), 1416-1427. (Read full article)
    25. Wade A, Rallabandi R, Lucas S, Oberg C, Gorusupudi A, Bernstein PS, Rainier JD (2021). The synthesis of the very long chain polyunsaturated fatty acid (VLC-PUFA) 32:6 n-3. Org Biomol Chem, 19(25), 5563-5566. (Read full article)
    26. Arunkumar R, Gorusupudi A, Li B, Blount JD, Nwagbo U, Kim HJ, Sparrow JR, Bernstein PS (2021). Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4-/-/Bco2-/- double knockout mice. Exp Eye Res, 209, 108680. (Read full article)
    27. Goerdt L, Sauer L, Vitale AS, Modersitzki NK, Fleckenstein M, Bernstein PS (2021). Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases. Transl Vis Sci Technol, 10(7), 11. (Read full article)
    28. da Palma MM, Igelman AD, Ku C, Burr A, You JY, Place EM, Wang NK, Oh JK, Branham KE, Zhang X, Ahn J, Gorin MB, Lam BL, Ronquillo CC, Bernstein PS, Nagiel A, Huckfeldt R, Cabrera MT, Kelly JP, Bakall B, Iannaccone A, Hufnagel RB, Zein WM, Koenekoop RK, Birch DG, Yang P, Fahim AT, Pennesi ME (2021). Characterization of the Spectrum of Ophthalmic Changes in Patients With Alagille Syndrome. Invest Ophthalmol Vis Sci, 62(7), 27. (Read full article)
    29. Addo EK, Gorusupudi A, Allman S, Bernstein PS (2021). The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study-carotenoid supplementation during pregnancy: ocular and systemic effects-study protocol for a randomized controlled trial. Trials, 22(1), 300. (Read full article)
    30. Gorusupudi A, Rallabandi R, Li B, Arunkumar R, Blount JD, Rognon GT, Chang FY, Wade A, Lucas S, Conboy JC, Rainier JD, Bernstein PS (2021). Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice. Proc Natl Acad Sci U S A, 118(6). (Read full article)
    31. Bernstein PS, Arunkumar R (2021). The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. J Lipid Res, 62, 100038. (Read full article)
    32. Bernstein PS, Ranganathan A (2021). The emerging roles of the macular pigment carotenoids throughout the lifespan and in prenatal supplementation. J Lipid Res, 100038. (Read full article)
    33. Sauer L, Vitale AS, Modersitzki NK, Bernstein PS (2020). Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond. Eye (Lond), 35(1), 93-109. (Read full article)
    34. Lakk M, Hoffmann GF, Gorusupudi A, Enyong E, Lin A, Bernstein PS, Toft-Bertelsen T, MacAulay N, Elliott MH, Kriaj D (2021). Membrane cholesterol regulates TRPV4 function, cytoskeletal expression, and the cellular response to tension. J Lipid Res, 62, 100145. (Read full article)
    35. Hicks PM, Haaland B, Feehan M, Crandall AS, Pettey JH, Nuttall E, Self W, Hartnett ME, Bernstein P, Vitale A, Shakoor A, Shulman JP, Sieminski SF, Kim I, Owen LA, Murtaugh MA, Noyes A, DeAngelis MM (2020). Systemic Disease and Ocular Comorbidity Analysis of Geographically Isolated Federally Recognized American Indian Tribes of the Intermountain West. J Clin Med, 9(11). (Read full article)
    36. Arunkumar R, Gorusupudi A, Bernstein PS (2020). The macular carotenoids: A biochemical overview. Biochim Biophys Acta Mol Cell Biol Lipids, 1865(11), 158617. (Read full article)
    37. Rai BB, Morley MG, Zangmo P, Tshering T, Khatiwara AN, Bernstein PS, Maddess T (2020). Retinal laser services in Bhutan: a 3-year national survey. BMC Ophthalmol, 20(1), 404. (Read full article)
    38. Vitale AS, Sauer L, Modersitzki NK, Bernstein PS (2020). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia. Transl Vis Sci Technol, 9(10), 33. (Read full article)
    39. Rai BB, Morley MG, Zangmo P, Tschering T, Khatiwara AN, Bernstein PS, Maddes T (2020). Surgical Management of VR Patients in Bhutan.
    40. Zucker CL, Bernstein PS, Schalek RL, Lichtman JW, Dowling JE (2020). A connectomics approach to understanding a retinal disease. Proc Natl Acad Sci U S A, 117(31), 18780-18787. (Read full article)
    41. Sauer L, Vitale AS, Milliken CM, Modersitzki NK, Blount JD, Bernstein PS (2020). Autofluorescence Lifetimes Measured with Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Are Affected by Age, but Not by Pigmentation or Gender. Transl Vis Sci Technol, 9(9), 2. (Read full article)
    42. Obana A, Gohto Y, Nakazawa R, Moriyama T, Gellermann W, Bernstein PS (2020). Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels. Sci Rep, 10(1), 10262. (Read full article)
    43. Zhai Y, Xu M, Dimopoulos IS, Birch DG, Bernstein PS, Holt J, Kirn D, Francis P, MacDonald IM (2020). Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method. Transl Vis Sci Technol, 9(7), 21. (Read full article)
    44. Li B, George EW, Rognon GT, Gorusupudi A, Ranganathan A, Chang FY, Shi L, Frederick JM, Bernstein PS (2020). Imaging lutein and zeaxanthin in the human retina with confocal resonance Raman microscopy. Proc Natl Acad Sci U S A, 117(22), 12352-12358. (Read full article)
    45. Sauer L, Vitale AS, Andersen KM, Hart B, Bernstein PS (2019). FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS. Retina, 40(4), 695-704. (Read full article)
    46. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS (2020). Spatial distribution of macular pigment estimated by autofluorescence imaging in elderly Japanese individuals. Jpn J Ophthalmol, 64(2), 160-170. (Read full article)
    47. Rai BB, Morley MG, Bernstein PS, Maddess T (2020). Pattern of vitreo-retinal diseases at the national referral hospital in Bhutan: a retrospective, hospital-based study. BMC Ophthalmol, 20(1), 51. (Read full article)
    48. Green-Gomez M, Bernstein PS, Curcio CA, Moran R, Roche W, Nolan JM (2019). Standardizing the Assessment of Macular Pigment Using a Dual-Wavelength Autofluorescence Technique. Transl Vis Sci Technol, 8(6), 41. (Read full article)
    49. Bernstein PS (2019). Does Dark Chocolate Enhance Visual Function? JAMA Ophthalmol, 137(12), 1380. (Read full article)
    50. Gantner ML, Eade K, Wallace M, Handzlik MK, Fallon R, Trombley J, Bonelli R, Giles S, Harkins-Perry S, Heeren TFC, Sauer L, Ideguchi Y, Baldini M, Scheppke L, Dorrell MI, Kitano M, Hart BJ, Cai C, Nagasaki T, Badur MG, Okada M, Woods SM, Egan C, Gillies M, Guymer R, Eichler F, Bahlo M, Fruttiger M, Allikmets R, Bernstein PS, Metallo CM, Friedlander M (2019). Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. N Engl J Med, 381(15), 1422-1433. (Read full article)
    51. Sauer L, Calvo CM, Vitale AS, Henrie N, Milliken CM, Bernstein PS (2019). Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy. Ophthalmol Retina, 3(10), 814-825. (Read full article)
    52. Strauss RW, Kong X, Ho A, Jha A, West S, Ip M, Bernstein PS, Birch DG, Cideciyan AV, Michaelides M, Sahel JA, Sunness JS, Traboulsi EI, Zrenner E, Pitetta S, Jenkins D, Hariri AH, Sadda S, Scholl HPN, ProgStar Study Group (2019). Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11. JAMA Ophthalmol, 137(10), 1134-1145. (Read full article)
    53. Ronquillo CC, Sauer L, Morgan D, Heckzo JB, Creel DJ, Mamalis N, DeAngelis MM, Hagemann GS, Bernstein PS (2019). ABSENCE OF MACULAR DEGENERATION IN A PATIENT WITH ACERULOPLASMINEMIA. Retina, 39(9), 1824-1828. (Read full article)
    54. Sauer L, Li B, Bernstein PS (2019). Ocular Carotenoid Status in Health and Disease. Annu Rev Nutr, 39, 95-120. (Read full article)
    55. Gorusupudi A, Chang FY, Nelson K, Hageman GS, Bernstein PS (2019). n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models. Mol Nutr Food Res, 63(15), e1801058. (Read full article)
    56. Sauer L, Komanski CB, Vitale AS, Hansen ED, Bernstein PS (2019). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 60(8), 3054-3063. (Read full article)
    57. Obana A, Gohto Y, Gellermann W, Ermakov IV, Sasano H, Seto T, Bernstein PS (2019). Skin Carotenoid Index in a large Japanese population sample. Sci Rep, 9(1), 9318. (Read full article)
    58. Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS, Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN, ProgStar Study Group, ProgStar Study Group (2018). Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8. Br J Ophthalmol, 103(3), 390-397. (Read full article)
    59. Hicks PM, Melendez SAC, Vitale A, Self W, Hartnett ME, Bernstein P, Morgan DJ, Feehan M, Shakoor A, Kim I, Owen LA, DeAngelis MM (2019). Genetic Epidemiologic Analysis of Hypertensive Retinopathy in an Underrepresented and Rare Federally Recognized Native American Population of the Intermountain West. J Community Med Public Health, 3(1). (Read full article)
    60. Trujillo Tanner C, Caserta MS, Kleinschmidt JJ, Clayton MS, Bernstein PS, Guo JW (2018). Conducting Research With Older Adults With Vision Impairment: Lessons Learned and Recommended Best Practices. Gerontol Geriatr Med, 4, 2333721418812624. (Read full article)
    61. Ronquillo CC, Wegner K, Calvo CM, Bernstein PS (2018). Genetic Penetrance of Macular Telangiectasia Type 2. JAMA Ophthalmol, 136(10), 1158-1163. (Read full article)
    62. Sauer L, Andersen KM, Dysli C, Zinkernagel MS, Bernstein PS, Hammer M (2018). Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. J Biomed Opt, 23(9), 1-20. (Read full article)
    63. Sauer L, Andersen KM, Dysli C, Zinkernagel MS, Bernstein PS, Hammer M (2018). Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy (Erratum). J Biomed Opt, 23(9), 1. (Read full article)
    64. Cheng JL, Farnsworth K, Bernstein PS (2018). Choroideremia in a Woman With Turner Syndrome. JAMA Ophthalmol, 136(9), 1076-1078. (Read full article)
    65. Li B, Rognon GT, Mattinson T, Vachali PP, Gorusupudi A, Chang FY, Ranganathan A, Nelson K, George EW, Frederick JM, Bernstein PS (2018). Supplementation with macular carotenoids improves visual performance of transgenic mice. Arch Biochem Biophys, 649, 22-28. (Read full article)
    66. Andersen KM, Sauer L, Gensure RH, Hammer M, Bernstein PS (2018). Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Transl Vis Sci Technol, 7(3), 20. (Read full article)
    67. Sauer L, Andersen KM, Li B, Gensure RH, Hammer M, Bernstein PS (2018). Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment. Invest Ophthalmol Vis Sci, 59(7), 3094-3103. (Read full article)
    68. Obana A, Gohto Y, Sasano H, Gellermann W, Sharifzadeh M, Seto T, Bernstein PS (2018). Grade of Cataract and Its Influence on Measurement of Macular Pigment Optical Density Using Autofluorescence Imaging. Invest Ophthalmol Vis Sci, 59(7), 3011-3019. (Read full article)
    69. Arunkumar R, Calvo CM, Conrady CD, Bernstein PS (2018). What do we know about the macular pigment in AMD: the past, the present, and the future. Eye (Lond), 32(5), 992-1004. (Read full article)
    70. Bhosale P, Zhao DY, Bernstein PS (2007). HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci, 48(2), 543-9. (Read full article)
    71. Bhosale P, Bernstein PS (2005). Microbial xanthophylls. Appl Microbiol Biotechnol, 68(4), 445-55. (Read full article)
    72. Bernstein PS, Gellermann W (2002). Measurement of carotenoids in the living primate eye using resonance Raman spectroscopy. Methods Mol Biol, 196, 321-9. (Read full article)

    Review

    1. Nwagbo U, Bernstein PS (2023). Understanding the Roles of Very-Long-Chain Polyunsaturated Fatty Acids (VLC-PUFAs) in Eye Health. [Review]. Nutrients, 15(14). (Read full article)
    2. Arunkumar R, Bernstein PS (2023). Macular Pigment Carotenoids and Bisretinoid A2E. [Review]. Adv Exp Med Biol, 1415, 15-20. (Read full article)
    3. Grant MB, Bernstein PS, Boesze-Battaglia K, Chew E, Curcio CA, Kenney MC, Klaver C, Philp NJ, Rowan S, Sparrow J, Spaide RF, Taylor A (2022). Inside out: Relations between the microbiome, nutrition, and eye health. [Review]. Exp Eye Res, 224, 109216. (Read full article)

    Editorial

    1. Bernstein PS, Sauer L (2019). Fluorescence Lifetime Imaging Ophthalmoscopy: A New Era of Autofluorescence Imaging of the Human Retina. Retina, 39(5), 817-819. (Read full article)

    Letter

    1. Simonett JM, Shakoor A, Bernstein PS (2020). Intentional retinal injury with handheld lasers is an underrecognized form of self-harm. [Letter to the editor]. J Affect Disord, 281, 503-504. (Read full article)

    Other

    1. Kuppermann BD, Bernstein P, Mones J, Do DV, Neumann R, Rosenfeld PJ (2019). ISOPT Clinical Hot Topic Panel Discussion on Medical Treatment of Retinal Diseases. J Ocul Pharmacol Ther (35(8), pp. 424-432). United States. (Read full article)

    Patent

    1. Gellermann W, McClane RW, Bernstein PS (2007). Optical method and apparatus for determining status of agricultural products. U.S. Patent No. 10.271.914. Washington, D.C.:U.S. Patent and Trademark Office.
    2. McClane RW, Gellermann W, Bernstein PS (2006). Method and apparatus for Raman imaging of macular pigments. U.S. Patent No. 7.039.452. Washington, D.C.:U.S. Patent and Trademark Office.
    3. Gellermann W, McClane RW, Katz NB, Bernstein PS (2001). Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue. U.S. Patent No. 6,205,354. Washington, D.C.:U.S. Patent and Trademark Office.
    4. Bernstein PS, Gellermann W, McClane RW (1999). Method and system for measurement of macular carotenoid levels. U.S. Patent No. 5,873,831. Washington, D.C.:U.S. Patent and Trademark Office.